Stay Up
to Date
Stay Up
to Date
Breaking News,
Updates, & More
Breaking News,
Updates, & More
Click Here to
Subscribe
Click Here to
Subscribe

Phoebe Starr

Authored Items
MONALEESA-7 Sets New Standard of Care for Premenopausal Women with Advanced Breast Cancer
Phoebe Starr
TON - August 2019, Vol 12, No 4 in Breast Cancer
Studies Show ACA Reduces Disparities and Increases Access to Earlier Diagnosis and Treatment
Phoebe Starr
TON - August 2019, Vol 12, No 4 in ASCO
Osimertinib plus Savolitinib Promising for Non–Small-Cell Lung Cancer with MET-Driven Resistance
Phoebe Starr
TON - June 2019, Vol 12, No 3 in Lung Cancer
High Tumor Mutation Burden Predictive Biomarker for Survival in Metastatic Non–Small-Cell Lung Cancer
Phoebe Starr
TON - June 2019, Vol 12, No 3 in Lung Cancer
Gilteritinib a New Standard of Care for Relapsed or Refractory AML with FLT3 Mutation
Phoebe Starr
TON - June 2019, Vol 12, No 3 in Leukemia
Infigratinib a Novel, Potent Selective TKI Targeting FGFR Fusions in Different Tumor Types
Phoebe Starr
TON - June 2019, Vol 12, No 3 in Emerging Therapies
Umbralisib Shows Encouraging Results in Relapsed or Refractory Marginal-Zone Lymphoma
Phoebe Starr
TON - June 2019, Vol 12, No 3 in Lymphoma
Explosive Development of BCMA CAR T-Cell Therapies for Multiple Myeloma
Phoebe Starr
TON - April 2019, Vol 12, No 2 in Immunotherapy
5 mg Tamoxifen as Effective as 20 mg Daily in Early Localized Breast Cancer
Phoebe Starr
TON - February 2019, Vol 12, No 1 in Breast Cancer
Weight-Loss Intervention in Women with Breast Cancer Works Only with Adherence
Phoebe Starr
TON - February 2019, Vol 12, No 1 in Breast Cancer
Checkpoint Inhibitor a New Approach to Jump-Start a Waning Response to CAR T-Cell Therapy
Phoebe Starr
TON - February 2019, Vol 12, No 1 in Immunotherapy
Paradigm Shift: Radiation a New Standard in Prostate Cancer with Low Metastatic Burden
Phoebe Starr
TON - February 2019, Vol 12, No 1 in Prostate Cancer
Researchers Identify First Mutation to Explain Resistance to Venetoclax
Phoebe Starr
TON - February 2019, Vol 12, No 1 in Leukemia
First-Line Olaparib a New Standard in Women with Newly Diagnosed, BRCA-Positive Advanced Ovarian Cancer?
Phoebe Starr
TON - February 2019, Vol 12, No 1 in Ovarian Cancer
Nivolumab plus Ipilimumab Combo Controls Brain Metastases in Patients with Melanoma
Phoebe Starr
TON - November 2018, Vol 11, No 5 in Melanoma
TLR9 Agonist plus Immunotherapy May Overcome Resistance to PD-1 Inhibition
Phoebe Starr
TON - November 2018, Vol 11, No 5 in Emerging Therapies
With Access to Care, Black Men in the United States Have Same Prostate Cancer Outcomes as White Men
Phoebe Starr
TON - September 2018, Vol 11, No 4 in Prostate Cancer
Acquired HER2 Mutations in Metastatic Breast Cancer Confer Resistance to ER-Directed Therapy
Phoebe Starr
TON - July 2018, Vol 11, No 3 in Breast Cancer
Chlamydia Trachomatis Infection Doubles the Risk for Ovarian Cancer
Phoebe Starr
TON - May 2018, Vol 11, No 2 in Ovarian Cancer
Adjuvant Chemotherapy in Upper-Tract Urothelial Cancer Shows Impressive Gains in the POUT Trial
Phoebe Starr
TON - May 2018, Vol 11, No 2 in Genitourinary Cancers
Emerging Safety Data with Checkpoint Inhibitors
Phoebe Starr
TON - November 2017, Vol 10, No 6 in Conference Correspondent
Psychological Distress in Patients with Cancer Warrants Attention
Phoebe Starr
TON - November 2017, Vol 10, No 6 in Conference Correspondent
Patients’ Chemotherapy-Related Side-Effect Concerns Have Evolved, But Hair Loss Remains Significant
Phoebe Starr
TON - November 2017, Vol 10, No 6 in Conference Correspondent
Increased Cancer Risk in Postmenopausal Women with Central Obesity
Phoebe Starr
TON - November 2017, Vol 10, No 6 in Conference Correspondent
Patients’ Fears of Radiation Side Effects Largely Unfounded
Phoebe Starr
TON - November 2017, Vol 10, No 6 in Conference Correspondent
Novel Drug “Home Run” for TRK Mutation–Positive Tumors
Phoebe Starr
TON - November 2017, Vol 10, No 6 in Emerging Therapies
Healthy Lifestyle Improves Survival in Patients with Colon Cancer
Phoebe Starr
TON - September 2017, Vol 10, No 5 in Colorectal Cancer, Conference Correspondent
8-Week Internet-Based Psychological Intervention Reduces Stress in Patients Newly Diagnosed with Cancer
Phoebe Starr
TON - September 2017, Vol 10, No 5 in Conference Correspondent
More Support for Regular Use of Low-Dose Aspirin
Phoebe Starr
TON - September 2017, Vol 10, No 5 in Conference Correspondent
Cardiotoxicity with Targeted Therapies Is Rare, but Requires Attention
Phoebe Starr
TON - September 2017, Vol 10, No 5 in Conference Correspondent
Survivorship Care Evolves with Fine-Tuning
Phoebe Starr
TON - July 2017, Vol 10, No 4 in Survivorship
Reasons for Emergency Department Visits Related to Immune Checkpoint Inhibitor Treatment
Phoebe Starr
TON - July 2017, Vol 10, No 4 in Side-Effects Management, Side-Effects Management
Hormonal Therapy Associated with Anxiety in Men with Localized Prostate Cancer
Phoebe Starr
TON - May 2017, Vol 10, No 3 in Genitourinary Cancers
New NCCN Distress Guidelines and Tools Encourage Patients to Speak Up
Phoebe Starr
TON - May 2017, Vol 10, No 3 in Conference Correspondent, NCCN
Discontinuing Immunotherapy Because of Adverse Effects May Not Compromise Efficacy
Phoebe Starr
TON - May 2017, Vol 10, No 3 in Side-Effects Management, Side-Effects Management
Toxicities of Immunotherapy Require Awareness, Education
Phoebe Starr
TON - May 2017, Vol 10, No 3 in Side-Effects Management, Side-Effects Management
Autologous Breast Reconstruction Has Better Outcomes Than Implants in Patients Receiving Radiotherapy
Phoebe Starr
TON - March 2017, Vol 10, No 2 in Breast Cancer
Specific Menopausal Symptoms Associated with Nonadherence to Hormonal Therapy in Women at Risk for Breast Cancer
Phoebe Starr
TON - March 2017, Vol 10, No 2 in Breast Cancer
R-CHOP Prevails Over Dose-Adjusted EPOCH-R as Standard of Care for Diffuse Large B-Cell Lymphoma
Phoebe Starr
Web Exclusives in Conference Correspondent, In the News
Strategies to Reduce the Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Phoebe Starr
Web Exclusives in Conference Correspondent, In the News
Increased Attention to Cardiovascular Events in DLBCL Warranted
Phoebe Starr
TON - January 2017, Vol 10, No 1 in Conference Correspondent
Use Caution When Placing Catheters in Children with Cancer
Phoebe Starr
TON - January 2017, Vol 10, No 1 in Conference Correspondent
Call to Action: Address Patients’ Sexual Health
Phoebe Starr
TON - November 2016, Vol 9, No 6 in Supportive Care
Older Drugs in “New Clothes” Achieve Superior Outcomes
Phoebe Starr
TON - November 2016, Vol 9, No 6 in Hematologic Cancers
Aggressive End-of-Life Care Continues to Be Offered to Younger Patients with Cancer
Phoebe Starr
TON - September 2016, Vol 9, No 5 in Best Practices, Palliative Care
Aspirin Reduces Risk for Prostate Cancer Death
Phoebe Starr
TON March 2016 Vol 9 No 2 in Genitourinary Cancers
Docetaxel Does Not Compromise Long-Term QOL in Men with Metastatic Hormone-Sensitive Prostate Cancer
Phoebe Starr
TON March 2016 Vol 9 No 2 in Genitourinary Cancers
Active Holistic Surveillance Incorporates Diet, Supplements, Exercise for Low-Risk and Low-Intermediate–Risk Prostate Cancer
Phoebe Starr
TON March 2016 Vol 9 No 2 in Genitourinary Cancers
Chemotherapy, Radiation Safe During Pregnancy in Second or Third Trimester
Phoebe Starr
TON November 2015 Vol 8 No 6 in Supportive Care
ABCs of Immunotherapy
Phoebe Starr
TON September 2015 Vol 8 No 5 in Online First
The State of Antibody-Drug Conjugates in 2015
Phoebe Starr
TON September 2015 Vol 8 No 5 in Drug Therapies
Being Single Raises Risks of Death for Patients with Cancer
Phoebe Starr
TON July 2015 Vol 8 No 4 in Supportive Care
No Role for Adjuvant Sorafenib or Sunitinib in Locally Advanced Kidney Cancer
Phoebe Starr
TON May 2015 Vol 8 No 3 in Genitourinary Cancers
AR-V7 Predicts Chemotherapy Sensitivity in Metastatic Prostate Cancer
Phoebe Starr
TON May 2015 Vol 8 No 3 in Genitourinary Cancers
Novel Agent Effective for the Management of Cancer-Related Cachexia
Phoebe Starr
TON - January 2015 Vol 8 No 1 in Supportive Care
Role of Radiation and Imaging in DCIS Explained
Phoebe Starr
TON - January/February 2014 Vol 7 No 1 in Breast Cancer
Pazopanib: First Positive Maintenance Trial
Phoebe Starr
TON - December 2013 Vol 6 No 11 in Gynecologic Cancers
Two-Thirds of Women Experience Musculoskeletal Toxicity on Aromatase Inhibitors and 22.9% Discontinue Therapy
Phoebe Starr
TON - March 2013, Vol 6, No 2 in Breast Cancer
Last modified: December 21, 2012